GZMB and neoplasm: We confirmed that granzyme B production upon anti-PD1 treatment was impaired in tumor-infiltrating AhR-deficient CD8 T cells (Supplementary Fig. 8b), contrasting with granzyme B production by WT CD8 T cells being similar in both diet groups (Fig. 4c).